Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular Diseases.

Nonalcoholic fatty liver disease (NAFLD) is an underappreciated independent risk factor for atherosclerotic cardiovascular diseases (ASCVDs). In recent years, the risk of ASCVD has increased along with the prevalence of NAFLD. ASCVD events are highly prevalent and are the main contributor to death in patients with NAFLD.

Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke.

Objectives: Atrial fibrillation (AF) is the most common arrhythmia treated in clinical practice and the association of this arrhythmia with stroke has long been recognized. The combination of associated factors to identify stroke risk is still unclear; therefore, we aimed to determine the association between additional risk factors for non-valvular AF (NVAF) and the first onset stroke patients and investigate the predictive ability of additional risks factors such as cardiac biomarkers and AF status for odds of incident stroke.

Materials And Methods: We included 455 patients who suffered from NVAF divided into two distinct groups (case-control observational study).